INVESTIGATION OF BMI, ETC CHANGES FOLLOWING A SWITCH FROM OLANZAPINE

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. With this study, we hope to find out if aripiprazole can reverse weight gain and problems with high blood sugar, lipids or blood pressure that have developed while people have been taking olanzapine, resperidone or quetiapine.